Top 29 Merus investors
The most complete profiles first. Showing 29 of 29.
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Daniel OmsteadVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Verified email available
David BeierVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Marian NakadaVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Vijay MurthyVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Asish Xavier
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Jeanne Bolger
Venture Capital, Corporate Venture Capital, Investor · United Kingdom
Series AHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Dayton Misfeldt
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more
Contact details available
Florent Gros
Venture Capital, Investor · France
SeedBiotechnologyElectronic Health Records (EHR)Health and Hospital ServicesHealth DiagnosticsPortfolio: Merus, Binx Health, Immune Targeting Systems, Oculis and 4 more
Contact details available
Fred Craves
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Jason Akus
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Contact details available
Matt Kronmiller
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
carl goldfischer
Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more
Contact details available
Karl Rothweiler
Venture Capital, Micro VC, Investor · Netherlands
SeedHealth CareInformation Technology (IT)3D TechnologyBiotechnologyPortfolio: Cristal Therapeutics, Macrophage Pharma, InteRNA Technologies, Merus and 2 more
Contact details available
Eric van der Putten
Micro VC · Netherlands
Health CareInformation Technology (IT)3D TechnologyBiotechnologyPortfolio: Cristal Therapeutics, Macrophage Pharma, InteRNA Technologies, Merus and 2 more
Contact details available
Ernst Geutjes
Micro VC · Netherlands
Health CareInformation Technology (IT)3D TechnologyBiotechnologyPortfolio: Cristal Therapeutics, Macrophage Pharma, InteRNA Technologies, Merus and 2 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Rainier Therapeutics16
- XyloCor Therapeutics14
- Civitas Therapeutics14
- Iterum Therapeutics14
- NextCure14
- Galera Therapeutics11
- Hyperion Therapeutics10
- Binx Health10
- Kiniksa Pharmaceuticals9
- Pronota9
- Coherus Biosciences9
Frequently asked questions
How many Merus investors are on Angel Roster?
Angel Roster lists 29 Merus investors. 9 of them (31%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (25), Private Equity Firms (5) and Corporate Venture Capital Firms (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Merus investors invest in?
Among those that list a stage, the most common are Seed (8), Series B (4) and Series A (1).
Where are Merus investors based?
Most are based in the United States (18), the Netherlands (6) and the United Kingdom (2).
Which companies have Merus investors backed?
The most-backed portfolio companies among them are Rainier Therapeutics (16), XyloCor Therapeutics (14), Civitas Therapeutics (14), Iterum Therapeutics (14) and NextCure (14).
How do I contact Merus investors?
Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.